STAAR exists to raise critical funds for life-saving research for those with low-grade ovarian cancer.
Low-grade serous carcinoma is a rare form of ovarian cancer, representing less than 10% of all cases and affecting women at a much younger age than those typically diagnosed.
Like ovarian cancer overall, low-grade is most often diagnosed in later stages where prognosis is poor and the recurrence rate is upwards of 70%.
Low-grade is distinguished from other forms in that it grows slower, but is relatively chemo-resistant, resulting in many clinicians deeming it a "tricky opponent."
Specific research dedicated to low-grade ovarian cancer is desperately needed because it often doesn't react to current treatments like more common forms do.
For more information on low-grade serous carcinoma, please visit our friends at Cure Our Ovarian Cancer, the leading global charity dedicated to low-grade research.
Like ovarian cancer overall, low-grade is most often diagnosed in later stages where prognosis is poor and the recurrence rate is upwards of 70%.
Low-grade is distinguished from other forms in that it grows slower, but is relatively chemo-resistant, resulting in many clinicians deeming it a "tricky opponent."
Specific research dedicated to low-grade ovarian cancer is desperately needed because it often doesn't react to current treatments like more common forms do.
For more information on low-grade serous carcinoma, please visit our friends at Cure Our Ovarian Cancer, the leading global charity dedicated to low-grade research.
